Appili Therapeutics Inc.
APLIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | -$0 | $0 |
| % Growth | – | 100% | -111.6% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | -1,031.7% | – | -7,365.1% | -7.6% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -951.6% | – | -1,809.1% | -483.9% |
| EPS Diluted | -0.01 | -0.01 | 0.002 | -0.004 |
| % Growth | 2.9% | -642.1% | 144.2% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |